NeuProScan

What is NeuProScan?

NeuProScan is an AI platform that predicts whether someone might develop dementia by analyzing their MRI scans, with a focus on spotting early signs of Alzheimer’s disease before symptoms appear.

The model was trained on a large number of MRI scans, allowing it to detect subtle patterns and hidden indicators of preclinical Alzheimer’s by examining every pixel of a scan. The output is a risk prediction that serves as a “second opinion” for doctors, supporting more accurate diagnoses and patient care.

NeuProScan is not intended to replace a doctor’s judgment; it acts as an assistant that forecasts a patient’s future health. Because there are currently few consistent or easy ways to detect Alzheimer’s before symptoms appear, NeuProScan fills that gap with a non-intrusive method for early detection, aiming to improve early diagnosis and management so treatment can begin when it may be most effective.

Who created NeuProScan?

NeuProScan was developed by an AI company focused on predicting dementia from MRI scans. The specific founder is not named in the available information.

What is NeuProScan used for?

• Predicting dementia onset by analyzing MRI scans
• Early Alzheimer’s diagnosis, including cases with no noticeable symptoms — it can identify Alzheimer’s years in advance from a single MRI scan
• Providing a second opinion for doctors and healthcare professionals
• Forecasting patient health, helping patients and families plan for the future
• Optimizing PET scan usage, so expensive scans are used more effectively for patients and healthcare systems
• Supporting clinical trial participation and enabling earlier interventions, at a stage when treatments may be more effective

Key takeaway

NeuProScan addresses the lack of consistent, accessible pre-symptomatic Alzheimer’s diagnostic tools. By turning standard MRI scans into risk predictions, it supports doctors in making earlier, better-informed decisions about patient care.